Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 19 Jul 2024 18:00 CEST |
BIOSENIC | BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger | 20103010 Biotechnology | Other subject |
| 19 Jul 2024 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
| 19 Jul 2024 18:00 CEST |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | - |
| 19 Jul 2024 18:00 CEST |
BIOSENIC | BioSenic S.A. : Transparency notification received from Mr François Rieger | 20103010 Biotechnology | Other subject |
| 19 Jul 2024 08:30 CEST |
BEKAERT | Bekaert - Update over de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
| 19 Jul 2024 08:30 CEST |
BEKAERT | Bekaert - Update on the Liquidity Agreement | 55102010 Iron and Steel | Legal |
| 19 Jul 2024 08:30 CEST |
BEKAERT | Bekaert - Mise à jour relative au Contrat de liquidité | 55102010 Iron and Steel | Legal |
| 19 Jul 2024 08:00 CEST |
WERELDHAVE BELGIUM | Half-yearly financial report 30 June 2024 | 35102045 Retail REITs | New |
| 19 Jul 2024 08:00 CEST |
WERELDHAVE BELGIUM | Rapport financier semestriel 30 juin 2024 | 35102045 Retail REITs | New |
| 19 Jul 2024 08:00 CEST |
WERELDHAVE BELGIUM | Halfjaarlijks financieel verslag 30 juni 2024 | 35102045 Retail REITs | New |
| 19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Croissance soutenue du chiffre d'affaires et forte amélioration de l’EBITDAaL - Perspectives de l’EBITDAaL améliorées | 15102015 Telecommunications Services | Other subject |
| 19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Solide omzetgroei en sterke EBITDAaL performantie - EBITDAaL vooruitzichten verbeterd | 15102015 Telecommunications Services | Other subject |
| 19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Solid revenue growth and strong EBITDAaL performance - EBITDAaL guidance improved | 15102015 Telecommunications Services | Other subject |
| 18 Jul 2024 18:00 CEST |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 18 Jul 2024 17:45 CEST |
European Medical Solutions | EUROPEAN MEDICAL SOLUTIONS ( ex DMS Imaging) : Chiffre d'affaires du 1er semestre 2024. | 20103010 Biotechnology | Sales, Income, Commercial results |
| 18 Jul 2024 13:17 CEST |
SHURGARD | 20240717 SHUR - Interim Results H1 2024 release announcement | 35101010 Real Estate Holding and Development | Commercial results |
| 18 Jul 2024 07:00 CEST |
BIOSENIC | BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase avancée sur le trioxyde d'arsenic (ATO) ciblant la cGvHD | 20103010 Biotechnology | Corporate life |
| 18 Jul 2024 07:00 CEST |
ARGENX SE | argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 | 20103010 Biotechnology | Other subject |
| 18 Jul 2024 07:00 CEST |
BIOSENIC | BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD | 20103010 Biotechnology | Corporate life |
| 17 Jul 2024 16:39 CEST |
BARCO | Half Year Results 2024 | 10102030 Computer Hardware | Commercial results |
| 17 Jul 2024 07:30 CEST |
ONWARD MEDICAL | ONWARD® Medical Publishes Annual Sustainability Summary | 20101025 Health Services | - |
| 16 Jul 2024 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Openbaarmaking van een transparantiekennisgeving | 40204020 Clothing and Accessories | Other subject |
| 16 Jul 2024 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Disclosure of a transparency notification | 40204020 Clothing and Accessories | Other subject |
| 16 Jul 2024 08:32 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 16 Jul 2024 08:31 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 16 Jul 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 08/07/2024 to 12/07/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jul 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 08/07/2024 au 12/07/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jul 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 08/07/2024 tot 12/07/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 16 Jul 2024 08:00 CEST |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
| 16 Jul 2024 08:00 CEST |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
| 16 Jul 2024 08:00 CEST |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
| 16 Jul 2024 06:30 CEST |
ARGENX SE | argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China | 20103010 Biotechnology | Other subject |
| 15 Jul 2024 18:26 CEST |
GBL | GBL - Transacties op GBL-aandelen 15-07-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jul 2024 18:24 CEST |
GBL | GBL - Transactions sur actions propres 15-07-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jul 2024 18:22 CEST |
GBL | GBL - Transactions on GBL shares 15-07-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 15 Jul 2024 17:45 CEST |
SYENSQO | Syensqo - Acquisition d'actions propres | 55101000 Diversified Materials | Change in Capital |
| 15 Jul 2024 17:45 CEST |
SYENSQO | Syensqo - Verwerving van eigen aandelen | 55101000 Diversified Materials | Change in Capital |
| 15 Jul 2024 17:45 CEST |
SYENSQO | Syensqo - Acquisition of own shares | 55101000 Diversified Materials | Change in Capital |
| 15 Jul 2024 08:00 CEST |
NYXOAH SA | Nyxoah Nomme Scott Holstine Chief Commercial Officer | 20102010 Medical Equipment | Other subject |
| 15 Jul 2024 08:00 CEST |
NYXOAH SA | Nyxoah Appoints Scott Holstine as Chief Commercial Officer | 20102010 Medical Equipment | Other subject |
| 15 Jul 2024 07:12 CEST |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 15 Jul 2024 07:11 CEST |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
| 12 Jul 2024 18:00 CEST |
BIOSENIC | BioSenic S.A. : Transparency notification received from Véronique Pomi | 20103010 Biotechnology | Other subject |
| 12 Jul 2024 18:00 CEST |
BIOSENIC | BioSenic S.A. : Notification de transparence reçue de la part de Véronique Pomi | 20103010 Biotechnology | Other subject |
| 12 Jul 2024 10:00 CEST |
ONTEX GROUP | Ontex announces details for its Q2 and H1 2024 results publication | 45201020 Personal Products | Meetings / events |
| 12 Jul 2024 10:00 CEST |
ONTEX GROUP | Ontex kondigt details aan voor de resultatenpublicatie van het 2de kwartaal en 1ste jaarhelft van 2024 | 45201020 Personal Products | Meetings / events |
| 12 Jul 2024 08:15 CEST |
BEKAERT | Bekaert - Update on the Liquidity Agreement | 55102010 Iron and Steel | Legal |
| 12 Jul 2024 08:15 CEST |
BEKAERT | Bekaert - Mise à jour relative au Contrat de liquidité | 55102010 Iron and Steel | Legal |
| 12 Jul 2024 08:15 CEST |
BEKAERT | Bekaert - Update over de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
| 11 Jul 2024 18:00 CEST |
OXURION | Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 | 20103010 Biotechnology | - |